Tariffs in the news: legal challenges and new talks under Trump-era trade moves; still shaping prices and families. Trump: ex-president.
The US has maintained a 10% tariff on Chinese goods for 150 days, with plans to increase to 15%. The move follows a Supreme Court ruling that invalidated previous tariffs, creating ongoing uncertainty for businesses and supply chains. Companies are considering legal actions and strategic adjustments amid fluctuating trade policies.
European Union and Australia have signed a comprehensive free-trade agreement after nearly a decade of negotiations. The deal eliminates tariffs on most goods, expands market access, and includes provisions for critical minerals, electric vehicles, and agricultural products. Both sides still need ratification, with the agreement expected to boost trade and investment.
On April 2, 2026, President Trump signed executive orders imposing up to 100% tariffs on foreign-made patented pharmaceuticals that do not meet pricing or US manufacturing conditions. Companies with pricing deals and US production face zero tariffs; others face escalating tariffs over four years. The orders also revise tariffs on steel, aluminum, and copper products to be based on full US market value.
President Trump has completed a two‑day state visit to Beijing with US business chiefs, holding talks with Xi Jinping on trade, Taiwan, Iran and AI. Leaders have agreed to set up trade and investment councils; Trump has touted unspecified "fantastic" deals including a reported 200‑plane Boeing order while Chinese statements remain cautious.
A U.S. appeals court has paused a lower court ruling that found Trump-style Section 122 tariffs illegal, while debates over the authority and impact on consumers continue. The decision comes as refunds of previously imposed tariffs are being processed and a July expiration date looms or could be extended by Congress.